Company intelligence / Profile preview

Litha Pharma

Midrand, Gauteng, South Africalithahealthcare.co.za ↗
Ownership
Private
Employees
~475
Development stage
Other
01

Overview

As of acquisition, Litha Healthcare Group marketed over 60 products and had approximately 70 programs in development, spanning generics, originators, and vaccines. The acquisition expanded Litha’s portfolio and expected to increase its pro-forma pharmaceutical revenues by 60%[2].

Therapeutic areas
NeurologyDermatologyGastroenterologyOncologyMen's Health
Modalities
Small moleculeBiologicVaccine
Industry
Biotech
02

Partnerships

Aspen Pharmacare HoldingsBiovac InstituteMultiple undisclosed pharmaceutical and medical institutes

Beyond the preview

Go deeper on Litha Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Litha Pharma.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call